Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ramya Elangovan
Institution:
The University of Texas Medical Branch at Galveston
Observed institutions:
University of Illinois Chicago,
University of Illinois Chicago, Rockford campus,
The University of Texas Medical Branch at Galveston,
Sri Sivasubramaniya Nadar College of Engineering
ORCID:
0000-0001-5506-7999
Observed ORCID:
0000-0001-5506-7999
OpenAlex ID:
A5082512255
Elder Care System using IoT and Machine Learning in AWS Cloud
2020
·
Aparajith Srinivasan
, Nithya Natarajan
, et al.
·
IEEE International Conference on Smart Communities: Improving Quality of Life Using ICT, IoT and AI (HONET)
·
8
Complete Tolerogenic Adjuvant Stimulates Regulatory T Cell Response to Immunization
2023
·
Guoxing Zheng
, Yajun Geng
, et al.
·
The Journal of Immunology
·
4
PDF
1222 In situ CAR therapy using oRNA™ lipid nanoparticles regresses tumors in mice
2022
·
Robert Mabry
, Amy Becker
, et al.
·
Regular and Young Investigator Award Abstracts
·
4
PDF
1205 Surmounting conventional cell therapy limitations via in situ CAR therapy using oRNA™ lipid nanoparticles
2023
·
Amy Becker
, Alex Wesselhoeft
, et al.
·
Regular and Young Investigator Award Abstracts
·
1
PDF
Raising Endogenous Anti-HMGB1 IgM Antibody for Athero-Protection in the Apoe−/− Mouse Model of Atherosclerosis
2019
·
Anjhana Hariharasubramanian
, Ramya Elangovan
, et al.
·
The Journal of Immunology
·
1
Long-term ambient air pollution is not associated with circulating soluble urokinase plasminogen activator receptor
2026
·
Bahjat Z. Ghazzal
, Anis Ismail
, et al.
·
Environmental Epidemiology
suPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2D
2026
·
Anis Ismail
, Yiyuan Huang
, et al.
·
Diabetes Care
suPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2D
2026
·
Anis Ismail
, Yiyuan Huang
, et al.
suPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2D
2026
·
Anis Ismail
, Yiyuan Huang
, et al.
Complete tolerogenic response adjuvant stimulates Treg response to immunization
2023
·
Sri Sushma Santhi Janjam
, Yajun Geng
, et al.
·
The Journal of Immunology
PDF
Show more works
View as search
Works count:
10
Citation count:
18
H-index:
3
I10-index:
Year
Topic
Type